临床医学工程
臨床醫學工程
림상의학공정
CLINICAL MEDICAL ENGINEERING
2014年
6期
757-758
,共2页
杨晓仪%黎文成%付玉梅%张晓坤%古雅珏%梁惠芬%曾颖%李勰璘
楊曉儀%黎文成%付玉梅%張曉坤%古雅玨%樑惠芬%曾穎%李勰璘
양효의%려문성%부옥매%장효곤%고아각%량혜분%증영%리협린
慢性肝脏疾病%血清纤维化指标%肝功能指标
慢性肝髒疾病%血清纖維化指標%肝功能指標
만성간장질병%혈청섬유화지표%간공능지표
Chronic liver disease%Serum fibrosis indexs%Liver function indexs
目的:研究血清纤维化指标联合肝功能指标检测用于诊断慢性肝脏疾病的临床价值。方法病例选取2011年6月至2013年6月我院接诊的80例慢性肝脏疾病患者进行研究,并选择40例正常人作为正常组进行对照研究。检测分析血清纤维化指标和肝功能指标,并评定慢性肝脏疾病的阳性检出率。结果联合检测的阳性检出率(93.75%)明显高于纤维化指标检测(67.50%)和肝功能指标检测的阳性检出率(75.00%),比较有显著性差异(χ2=17.4790, P=0.0002)。慢性肝脏疾病患者的丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)均明显升高(P<0.01);肝硬化和肝癌患者的甲胎蛋白(AFP)均出现明显升高(P<0.01);透明质酸(HA)、Ⅳ型胶原(Ⅳ-C)及型前胶原(PCⅢNP)均出现明显升高(P<0.01)。结论血清纤维化指标联合肝功能指标检测用于诊断慢性肝脏疾病的临床价值较高,值得临床推广应用。
目的:研究血清纖維化指標聯閤肝功能指標檢測用于診斷慢性肝髒疾病的臨床價值。方法病例選取2011年6月至2013年6月我院接診的80例慢性肝髒疾病患者進行研究,併選擇40例正常人作為正常組進行對照研究。檢測分析血清纖維化指標和肝功能指標,併評定慢性肝髒疾病的暘性檢齣率。結果聯閤檢測的暘性檢齣率(93.75%)明顯高于纖維化指標檢測(67.50%)和肝功能指標檢測的暘性檢齣率(75.00%),比較有顯著性差異(χ2=17.4790, P=0.0002)。慢性肝髒疾病患者的丙氨痠氨基轉移酶(ALT)、天門鼕氨痠氨基轉移酶(AST)均明顯升高(P<0.01);肝硬化和肝癌患者的甲胎蛋白(AFP)均齣現明顯升高(P<0.01);透明質痠(HA)、Ⅳ型膠原(Ⅳ-C)及型前膠原(PCⅢNP)均齣現明顯升高(P<0.01)。結論血清纖維化指標聯閤肝功能指標檢測用于診斷慢性肝髒疾病的臨床價值較高,值得臨床推廣應用。
목적:연구혈청섬유화지표연합간공능지표검측용우진단만성간장질병적림상개치。방법병례선취2011년6월지2013년6월아원접진적80례만성간장질병환자진행연구,병선택40례정상인작위정상조진행대조연구。검측분석혈청섬유화지표화간공능지표,병평정만성간장질병적양성검출솔。결과연합검측적양성검출솔(93.75%)명현고우섬유화지표검측(67.50%)화간공능지표검측적양성검출솔(75.00%),비교유현저성차이(χ2=17.4790, P=0.0002)。만성간장질병환자적병안산안기전이매(ALT)、천문동안산안기전이매(AST)균명현승고(P<0.01);간경화화간암환자적갑태단백(AFP)균출현명현승고(P<0.01);투명질산(HA)、Ⅳ형효원(Ⅳ-C)급형전효원(PCⅢNP)균출현명현승고(P<0.01)。결론혈청섬유화지표연합간공능지표검측용우진단만성간장질병적림상개치교고,치득림상추엄응용。
Objective To study the clinical value of serum fibrosis indexs combined with liver function indexs for the diagnosis of chronic liver diseases. Methods 80 patients with chronic liver diseases from June 2011 to June 2013 in our hospital were selected to study. And 40 healthy adults were selected as the control group. The primary outcome was results of the detection of the serum fibrosis indexs and liver function indexs;and the secondary result was an analysis of the positive rate of chronic liver disease. Results The positive rate of joint detection (93.75%) was significantly higher than the fibrosis index detection (67.50%) and the liver function indexs testing positive rate (75.00%) , with significant difference (χ2=17.479 0, P=0.000 2). The alanine aminotransferase (ALT), aspartate aminotransferase (AST) of the patients with chronic liver diseases were significantly increased (P <0.01);the alpha-fetoprotein (AFP) of the patients with cirrhosis and liver cancer were significantly boosted (P <0.01). The hyaluronic acid (HA), type Ⅳ collagen (Ⅳ-C) and PCⅢNP of the patients with chronic liver diseases significantly increased (P <0.01). Conclusions The combined detection of serum fibrosis indexs and liver function indexs for the diagnosis of chronic liver disease has high clinical value for diagnosing chronic livers diseases, which is worthy of wide clinical application.